Drug Trial Radar · NCT03889249
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
Last checked: Nov 20, 2026Latest source record: May 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,600
Actual
Start
Dec 10, 2019
Primary completion
Apr 26, 2022
Study completion Apr 30, 2023
Sponsor
- Lead sponsor
- University of CalgaryAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 26, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed trial is a pragmatic, registry linked, prospective, randomized (1:1) controlled, open-label parallel group clinical trial with blinded endpoint assessment of 1600 patients to test if intravenous tenecteplase (0.25 mg/kg body weight, max dose 25 mg) is non-inferior to intravenous alteplase (0.9 mg/kg body weight) in patients with acute ischemic stroke otherwise eligible for intravenous thrombolysis as per standard care. All patients will have standard of care medical management on an acute stroke unit. There are no additional trial specific management recommendations. Patients will be followed for approximately 90-120 days.
Conditions
- Stroke, Acute
- Thromboses, Intracranial
Interventions
TenecteplaseDrug
Stroke Thrombolytic
AlteplaseDrug
Stroke Thrombolytic
Primary outcomes
What the sponsor says the trial is designed to measure.
- Modified Rankin Scale (mRS) 0-1 (freedom from disability)Time frame: By telephone Follow-up between 90-120 days
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
University of Calgary
Calgary, Alberta, Canada
Grey Nuns Hospital
Edmonton, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
Medicine Hat Regional Hospital
Medicine Hat, Alberta, Canada
Red Deer Regional Hospital
Red Deer, Alberta, Canada
Kelowna General Hospital
Kelowna, B.C., Canada
Royal Columbian Hospital
New Westminster, British Columbia, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
University of Manitoba
Winnipeg, Manitoba, Canada
Halifax Infirmary Queen Elizabeth II
Halifax, Nova Scotia, Canada
Hamilton Health Sciences General Hospital
Hamilton, Ontario, Canada
Kingston Health Science Centre
Kingston, Ontario, Canada
London Health Sciences
London, Ontario, Canada
Ottawa Civic Hospital
Ottawa, Ontario, Canada
St. Michaels Hospital
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Toronto Western Hospital
Toronto, Ontario, Canada
Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
CHUM -Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada
Univerisite Laval-Hopital de l'Enfant-Jesus
Québec, Quebec, Canada
Universite de Sherbrooke
Sherbrooke, Quebec, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.